Acurx Pharmaceuticals LLC Stock Math Transform Exponential Price Movement

ACXP Stock  USD 4.13  -0.88  -17.56%   
The math transform module provides an execution environment for Exponential Price Movement transformation and related indicators on Acurx Pharmaceuticals. It emphasizes price transformations that reveal shifts in trend structure while keeping volatility, risk, and performance context in view.

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Acurx Pharmaceuticals LLC Price Movement is a mathematical transformation function to describe exponentially increasing price patterns.

Acurx Pharmaceuticals Technical Analysis Modules

Most technical analysis of Acurx Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Acurx from various momentum indicators to cycle indicators. When you analyze Acurx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

The stock is currently experiencing above-average trading activities.Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is based in Staten Island, New York. Acurx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people. The stock overview for Acurx Pharmaceuticals summarizes business drivers, financial profile, and market behavior. The company is positioned within Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care. Current metrics include P/B of 4.22. Acurx Pharmaceuticals has a market cap of 15.36 M, ROE of -2.91%.

Methodology

Unless otherwise specified, financial data for Acurx Pharmaceuticals LLC is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Acurx (USA Stocks:ACXP) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Acurx Pharmaceuticals LLC is covered by 3 analysts. 1 analyst has submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Bernstein Research, Deutsche Bank, Morgan Stanley, BMO Capital Markets, Guggenheim Securities, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board

Become your own money manager

Tracking Acurx Pharmaceuticals inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run CEOs Directory Now

   

CEOs Directory

Screen CEOs from public companies around the world
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Investor Favorites Idea
Investor Favorites
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Social Domain Idea
Social Domain
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Advertising Idea
Advertising
Invested few shares
Data Storage Idea
Data Storage
Invested few shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 200 shares
ESG Investing Idea
ESG Investing
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 20 shares

Additional Tools for Acurx Stock Analysis

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stocks Directory
Find actively traded stocks across global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk